Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine

被引:24
作者
Ko, Jen-Chung [2 ,3 ,4 ]
Tsai, Min-Shao [1 ]
Kuo, Ya-Hsun [1 ]
Chiu, Yu-Fan [1 ]
Weng, Shao-Hsing [1 ]
Su, Ying-Chen [1 ]
Lin, Yun-Wei [1 ]
机构
[1] Natl Chiayi Univ, Dept Biochem Sci & Technol, Mol Oncol Lab, Chiayi 600, Taiwan
[2] Hsinchu Hosp, Dept Internal Med, Dept Hlth, Executive Yuan, Taiwan
[3] Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan
[4] Natl Chiao Tung Univ, Grad Inst Technol Law, Hsinchu, Taiwan
关键词
ERCC1; Rad51; Thymidine phosphorylase; Capecitabine; Emodin; ERK1/2; Cytotoxicity; Non-small cell lung cancer; CELL LUNG-CANCER; NUCLEOTIDE EXCISION-REPAIR; ADVANCED BREAST-CANCER; MESSENGER-RNA LEVELS; GROWTH-FACTOR; FLUOROURACIL CHEMOTHERAPY; 2ND-LINE CHEMOTHERAPY; TUMOR-CELLS; PHASE-II; SURVIVAL;
D O I
10.1016/j.bcp.2010.12.008
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Thymidine phosphorylase (TP) is the rate-limiting enzyme for the activation of capecitabine (pro-drug of fluorouracil), and as a useful predictor of tumor response to capecitabine-based chemotherapy. Overexpression of Rad51 and ERCC1 induce resistance to chemotherapeutic agents. Emodin, one of the main bioactive anthraquinone derivatives in the roots and rhizomes of numerous plants, possesses potent antitumor effects. Accordingly, we aimed to explore the molecular mechanism of emodin enhances the capecitabine-induced cytotoxicity through controlling Rad51, ERCC1, and TP expression in human non-small cell lung cancer (NSCLC). The results show that capecitabine increases the phosphorylation of MKK1/2-ERK1/2 and protein levels of Rad51 and ERCC1 through enhancing the protein stability. Depletion of endogenous Rad51 or ERCC1 expression by specific small interfering RNA transfection significantly increases capecitabine-induced cell death and growth inhibition. Emodin enhances the capecitabine-induced cytotoxic effects through ERK1/2 inactivation and decreasing the Rad51 and ERCC1 protein levels induced by capecitabine. Enhancement of ERK1/2 signaling by constitutively active MKK1/2 (MKK1/2-CA) results in increasing Rad51 and ERCC1 protein levels and cell viability in NSCLC cell lines treated with emodin and capecitabine. Interestingly, emodin enhances TP mRNA and protein expression in capecitabine treated NSCLC cell lines, and depletion of the TP expression decreases the cytotoxic effects induced by capecitabine and emodin. We conclude that enhancing the cytotoxicity to capecitabine by emodin is mediated by down-regulation the expression of Rad51 and ERCC1 and up-regulation TP expression. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:680 / 690
页数:11
相关论文
共 58 条
[1]
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy [J].
Azuma, Koichi ;
Komohara, Yoshihiro ;
Sasada, Tetsuro ;
Terazaki, Yasuhiro ;
Ikeda, Jiro ;
Hoshino, Tomoaki ;
Itoh, Kyogo ;
Yamada, Akira ;
Aizawa, Hisamichi .
CANCER SCIENCE, 2007, 98 (09) :1336-1343
[2]
Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells [J].
Bertrand, P ;
Lambert, S ;
Joubert, C ;
Lopez, BS .
ONCOGENE, 2003, 22 (48) :7587-7592
[3]
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].
Bhattacharjee, A ;
Richards, WG ;
Staunton, J ;
Li, C ;
Monti, S ;
Vasa, P ;
Ladd, C ;
Beheshti, J ;
Bueno, R ;
Gillette, M ;
Loda, M ;
Weber, G ;
Mark, EJ ;
Lander, ES ;
Wong, W ;
Johnson, BE ;
Golub, TR ;
Sugarbaker, DJ ;
Meyerson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795
[4]
Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex [J].
Choi, YJ ;
Ryu, KS ;
Ko, YM ;
Chae, YK ;
Pelton, JG ;
Wemmer, DE ;
Choi, BS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (31) :28644-28652
[5]
The structures of antioxidant and cytotoxic agents from natural source:: anthraquinones and tannins from roots of Rumex patientia [J].
Demirezer, LÖ ;
Kuruüzüm-Uz, A ;
Bergere, I ;
Schiewe, HJ ;
Zeeck, A .
PHYTOCHEMISTRY, 2001, 58 (08) :1213-1217
[6]
Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair [J].
Gaillard, PHL ;
Wood, RD .
NUCLEIC ACIDS RESEARCH, 2001, 29 (04) :872-879
[7]
Goto H, 2001, CANCER RES, V61, P469
[8]
Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer [J].
Han, JY ;
Hong, EK ;
Lee, SY ;
Yoon, SM ;
Lee, DH ;
Lee, JS .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (06) :650-654
[9]
A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma [J].
Han, JY ;
Lee, DH ;
Kim, HY ;
Hong, EK ;
Yoon, SM ;
Chun, JH ;
Lee, HG ;
Lee, SY ;
Shin, EH ;
Lee, JS .
CANCER, 2003, 98 (09) :1918-1924
[10]
Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells [J].
Huang, Xin-zhi ;
Wang, Jie ;
Huang, Chao ;
Chen, Yu-ying ;
Shi, Gui-ying ;
Hu, Qing-shen ;
Yi, Jing .
CANCER BIOLOGY & THERAPY, 2008, 7 (03) :468-475